摘要
目的评价瑞芬太尼联合异丙酚用于房颤患者电复律麻醉的效果。方法将因房颤需接受电复律治疗的患者共65例,按入选顺序随机分为AB两组,A组34例接受异丙酚麻醉,B组31例接受瑞芬太尼联合异丙酚麻醉,观察两组在麻醉效果、苏醒状况、麻醉后不良反应、血流动力学指标等方面的差异。结果 B组在麻醉效果、术中知晓等方面与对照组比较,无统计学意义(P>0.05),且B组麻醉术后苏醒时间、血流动力学指标优于A组(P<0.05)。结论瑞芬太尼联合异丙酚更适合用于房颤患者电复律麻醉。
Objective Evaluation of anesthesia results of remifentanil and propofol for patients with atrial flbrlllatmn electrical cardioversion.Methods Total 65 cases required to undergo electrical cardioversion therapy due to atrial fibrillation were randomly divided into the A ＆B groups, A group of 34 cases, according to the selected order received pr^pofol anesthesia, B group 31 patients received remifentanil and propofol anesthesia, the onset time of anesthesia, the awaken time and hemodynamic parameters, postoperative adverse reactions were compared.Results Group B in the effects of anesthesia, postoperative recovery situation , intraoperative awareness and other aspects with no significant difference（P〉0.05）between the two groups, The awaken time and the change of the hemodynamic parameters in group B was less than group A （P〈0.05）.Conclusion Remifentanil and propofol is more suitable for patients with atrial fibrillation electrical cardioversion anesthesia.
出处
《中国卫生产业》
2013年第32期108-109,共2页
China Health Industry
关键词
瑞芬太尼
异丙酚
房颤
电复律
麻醉
Remifentanil
Propofol
Atrial fibrillation
Cardioversion technique
Anesthesia
